- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on C-difficile in New Zealand
Total 565 results
-
State University of New York at BuffaloWithdrawnC. Difficile InfectionUnited States
-
Vedanta Biosciences, Inc.RecruitingClostridium Difficile Infection Recurrence | Recurrent Clostridium Difficile Infection | Clostridium Difficile | Diarrhea Infectious | CDI | Clostridium Difficile Infections | Clostridioides Difficile Infection | C.Difficile Diarrhea | Clostridioides Difficile Infection Recurrence | C. Diff InfectionUnited States
-
DeinoveRecruitingClostridium Difficile (C. Difficile)United States, Canada
-
Finch Research and Development LLC.Medpace, Inc.CompletedClostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal TransplantUnited States, Canada
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | C. Difficile InfectionUnited States
-
Gilead SciencesCompleted
-
Antipodean Pharmaceuticals, Inc.Completed
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral InfectionUnited States, New Zealand
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Gilead SciencesCompleted
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Finch Research and Development LLC.TerminatedRecurrent C. Difficile InfectionUnited States, Canada
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Novartis PharmaceuticalsTerminated
-
Syneos HealthF-star Therapeutics, Inc.CompletedHepatitis C InfectionAustralia, New Zealand
-
Vedanta Biosciences, Inc.CompletedClostridium Difficile Infection | Clostridium Difficile Infection Recurrence | Clostridium Difficile | CDI | Clostridioides Difficile Infection | Clostridioides Difficile | Clostridioides Difficile Infection RecurrenceUnited States, Canada
-
Alios Biopharma Inc.Vertex Pharmaceuticals IncorporatedTerminatedHepatitis C, ChronicAustralia, New Zealand
-
Alios Biopharma Inc.CompletedChronic Hepatitis CNew Zealand, Moldova, Republic of, Mauritius, United Kingdom
-
PfizerCompletedClostridium Difficile Associated DiseaseUnited States
-
Gilead SciencesCompletedHepatitis C VirusUnited States, New Zealand
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
Presidio Pharmaceuticals, Inc.CompletedHepatitis C, ChronicUnited States, Australia, New Zealand
-
PfizerCompletedClostridium Difficile Associated DiseaseUnited States
-
Gilead SciencesCompletedPost Liver Transplant | Recurrent Chronic Hepatitis C VirusUnited States, Spain, New Zealand, France, Germany
-
Bio-K Plus International Inc.Sprim Advanced Life SciencesSuspendedRecurrent Clostridium Difficile InfectionUnited States
-
Gilead SciencesCompletedHCV InfectionUnited States, Germany, New Zealand
-
Icahn School of Medicine at Mount SinaiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
PfizerCompletedClostridium Difficile Associated DiseaseUnited States
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States, Canada, Slovakia, Poland, New Zealand, France, Australia
-
PfizerCompletedClostridium Difficile Associated DiseaseUnited States
-
Macfarlane Burnet Institute for Medical Research...St Vincent's Hospital MelbourneCompletedHepatitis CAustralia, New Zealand
-
Kirby InstituteCompletedDAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)Hepatitis CAustralia, New Zealand
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)RecruitingIntubation Complication | Intubation; Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Japan, Italy, New Zealand, Singapore, Australia, Austria, Germany, India, United Kingdom
-
PfizerActive, not recruitingClostridoides Difficile Associated DiseaseUnited States
-
Seres Therapeutics, Inc.Syneos HealthCompletedClostridium DifficileUnited States
-
Vertex Pharmaceuticals IncorporatedTerminatedChronic Hepatitis C Virus InfectionUnited States, New Zealand
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedIntubation Complication | Intubation;Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Singapore
-
Janssen Research & Development, LLCTerminated
-
PharmassetHoffmann-La RocheCompletedHealthy Volunteers | Hepatitis C VirusUnited States, Puerto Rico, New Zealand
-
Gilead SciencesCompletedHCV InfectionUnited States, New Zealand, Germany
-
Maimonides Medical CenterCompletedClostridium Difficle Colitis | Clostridium Difficle Associated DiseaseUnited States
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico